HGINFRA.NS(HGINFRA.NS)
HGINFRA.NS
No analyst ratings available
No analyst price targets available for HGINFRA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $61.64B | $69.74B | $83.80B |
| Low | $55.36B | $65.30B | $74.05B |
| High | $68.11B | $78.49B | $93.40B |
| EBITDA Avg | $13.82B | $15.64B | $18.79B |
| Low | $12.41B | $14.64B | $16.60B |
| High | $15.27B | $17.60B | $20.94B |
| EBIT Avg | $11.10B | $12.56B | $15.09B |
| Low | $9.97B | $11.76B | $13.34B |
| High | $12.27B | $14.14B | $16.82B |
| Net Income Avg | $3.75B | $4.70B | $6.40B |
| Low | $2.61B | $3.79B | $6.12B |
| High | $5.54B | $6.92B | $7.97B |
| EPS Avg | $63.84 | $79.43 | $106.17 |
| Low | $39.94 | $58.03 | $93.74 |
| High | $84.80 | $105.97 | $122.11 |
| Analysts (Rev / EPS) | 10 / 7 | 10 / 9 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $11.43B | $15.14B | $17.14B |
| Low | $11.43B | $15.14B | $17.14B |
| High | $11.43B | $15.14B | $17.14B |
| EBITDA Avg | $2.56B | $3.39B | $3.84B |
| Low | $2.56B | $3.39B | $3.84B |
| High | $2.56B | $3.39B | $3.84B |
| EBIT Avg | $2.06B | $2.73B | $3.09B |
| Low | $2.06B | $2.73B | $3.09B |
| High | $2.06B | $2.73B | $3.09B |
| Net Income Avg | $249M | $721M | $956M |
| Low | $249M | $721M | $956M |
| High | $249M | $721M | $956M |
| EPS Avg | $3.80 | $11.00 | $14.60 |
| Low | $3.80 | $11.00 | $14.60 |
| High | $3.80 | $11.00 | $14.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |